- Home
- NVCT vs AMPX Comparison
NVCT vs AMPX Comparison
Compare NVCT & AMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- AMPX
- Stock Information
- Founded
- NVCT 2020
- AMPX 2008
- Country
- NVCT United States
- AMPX United States
- Employees
- NVCT N/A
- AMPX N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- AMPX Industrial Machinery/Components
- Sector
- NVCT Health Care
- AMPX Miscellaneous
- Exchange
- NVCT Nasdaq
- AMPX Nasdaq
- Market Cap
- NVCT 119.4M
- AMPX 136.6M
- IPO Year
- NVCT 2022
- AMPX N/A
- Fundamental
- Price
- NVCT $8.07
- AMPX $1.59
- Analyst Decision
- NVCT Strong Buy
- AMPX Strong Buy
- Analyst Count
- NVCT 1
- AMPX 7
- Target Price
- NVCT $21.00
- AMPX $8.17
- AVG Volume (30 Days)
- NVCT 104.8K
- AMPX 1.9M
- Earning Date
- NVCT 11-06-2024
- AMPX 11-07-2024
- Dividend Yield
- NVCT N/A
- AMPX N/A
- EPS Growth
- NVCT N/A
- AMPX N/A
- EPS
- NVCT N/A
- AMPX N/A
- Revenue
- NVCT N/A
- AMPX $12,423,000.00
- Revenue This Year
- NVCT N/A
- AMPX $66.77
- Revenue Next Year
- NVCT N/A
- AMPX $311.17
- P/E Ratio
- NVCT N/A
- AMPX N/A
- Revenue Growth
- NVCT N/A
- AMPX 216.99
- 52 Week Low
- NVCT $5.85
- AMPX $0.61
- 52 Week High
- NVCT $12.10
- AMPX $6.02
- Technical
- Relative Strength Index (RSI)
- NVCT 79.50
- AMPX 68.24
- Support Level
- NVCT $6.40
- AMPX $1.24
- Resistance Level
- NVCT $6.65
- AMPX $1.44
- Average True Range (ATR)
- NVCT 0.39
- AMPX 0.17
- MACD
- NVCT 0.21
- AMPX 0.04
- Stochastic Oscillator
- NVCT 94.14
- AMPX 79.48
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About AMPX Amprius Technologies Inc.
Amprius Technologies Inc is engaged in the production of silicon anodes for high energy density lithium-ion batteries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites. All of its revenues is geographically earned in the United States.